Gara Jalqabaatti › Kansa Selii Skwaamoo Mataa fi Morma › Oregon › Portland
Qorannoo klinikaalii Kansa Selii Skwaamoo Mataa fi Morma Portland, OR keessatti
Qorannoo 19 Kansa Selii Skwaamoo Mataa fi Morma f Portland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Namoota walitti qabaa jiraSadarkaa 2/3
- Site #0113, Portland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #51, Portland
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Namoota walitti qabaa jiraSadarkaa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Site 02, Portland
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- ALX Center 6, Portland
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Portland
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Oregon Health And Science University, Portland
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Oregon Health and Science University, Portland
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Namoota walitti qabaa jiraSadarkaa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Namoota walitti qabaa jiraSadarkaa 3
- Oregon Health And Science University, Portland
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Namoota walitti qabaa jiraSadarkaa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · Miili 12 fagaatti
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Providence Cancer Institute, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Providence Cancer Institute Franz Clinic, Portland
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Providence Cancer Institute Franz Clinic, Portland
- Providence Oncology and Hematology Care Clinic - Westside, Portland
- Providence St. Vincent Medical Center- Investigational Drug Services, Portland
- fi 1 dabalataa
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Namoota walitti qabaa jiraSadarkaa 4
- OHSU Knight Cancer Institute, Portland
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- USA15-0, Portland
Qorannoo Kansa Selii Skwaamoo Mataa fi Morma magaalota biroo keessatti
- Houston, TXQorannoo 47
- Los Angeles, CAQorannoo 42
- Boston, MAQorannoo 40
- New York City, NYQorannoo 39
- Nashville, TNQorannoo 39
- St. Louis, MOQorannoo 28
- Arlington, VAQorannoo 26
- Philadelphia, PAQorannoo 26
- Chicago, ILQorannoo 26
- Atlanta, GAQorannoo 24
- San Antonio, TXQorannoo 22
- New Haven, CTQorannoo 22
Qorannoo biroo Portland keessatti
- Kansara Qara'a Non-Small CellQorannoo 46
- Saree (Gosoota Hunda)Qorannoo 34
- Saree OljooQorannoo 33
- Kansarii ProstateQorannoo 33
- Kansara MetastatikiiQorannoo 29
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Dhibee QaraQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 25
- Kansa EndometiriyaaliiQorannoo 24
- Kansarii PancreasQorannoo 19
- Cufama OnneeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.